What is the dosage of Diamox (acetazolamide) for treating metabolic alkalosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Acetazolamide for Metabolic Alkalosis

Oral acetazolamide at a single dose of 500 mg is effective for treating metabolic alkalosis in critically ill patients, with onset of action within 2 hours and sustained effect for 48-72 hours. 1, 2

Dosing Recommendations

Standard Dosing

  • Administer 500 mg acetazolamide intravenously or orally as a single dose for metabolic alkalosis in critically ill patients 2, 3
  • A single 500 mg dose is as effective as multiple doses of 250 mg every 6 hours for 24 hours, making single-dose therapy the preferred approach 3
  • The effect begins within 2 hours, reaches maximum effect at approximately 15.5 hours, and remains apparent at 48-72 hours 2

Pediatric Considerations

  • Acetazolamide may be less effective in pediatric cardiac patients (particularly those post-congenital heart disease repair) compared to noncardiac critically ill children 4
  • In noncardiac pediatric patients, acetazolamide successfully reduces plasma bicarbonate levels within 18 hours 4
  • The lack of response in cardiac patients persists even when compared to age-matched noncardiac patients, suggesting acetazolamide should not be routinely used for metabolic alkalosis in critically ill children with congenital heart disease 4

Mechanism of Action

Acetazolamide corrects metabolic alkalosis by decreasing serum strong ion difference (SID) through increased renal excretion of sodium without chloride, resulting in increased serum chloride. 1

  • The correction of pH (from 7.49 to 7.46) is maximal at 24 hours and sustained throughout the observation period 1
  • Serum bicarbonate decreases by an average of 6.4 mmol/L at 24 hours, with normalization of base excess and pH 2
  • The mechanism involves increased urinary sodium excretion without proportional chloride excretion, leading to hyperchloremia that corrects the alkalosis 1

Clinical Context and Indications

When to Use Acetazolamide

  • Acetazolamide is indicated for metabolic alkalosis resistant to fluid and electrolyte therapy (serum potassium ≥ 4 mEq/L) in mechanically ventilated patients 3
  • The KDIGO guidelines suggest acetazolamide may be helpful for metabolic alkalosis associated with diuretic therapy, particularly when combined with loop or thiazide diuretics 5
  • Consider acetazolamide when rapid correction of metabolic alkalosis is needed or when conventional fluid and electrolyte therapy cannot be tolerated 6

Alternative Therapies

  • Conventional treatment involves correcting fluid and electrolyte deficits first, allowing the body's own mechanisms to correct the alkalosis 6
  • For severe cases requiring more rapid correction, intravenous hydrochloric acid (0.1-0.2 N) may be administered through a central venous catheter, particularly in patients with hepatic dysfunction 6
  • Ammonium chloride is the primary alternative mineral acid, but requires hepatic conversion and should be avoided in patients with hepatic or severe renal dysfunction 6

Monitoring and Safety

Expected Response

  • Serum bicarbonate should decrease by approximately 6-7 mEq/L within 24 hours of acetazolamide administration 2, 3
  • Both single-dose (500 mg) and multiple-dose (250 mg every 6 hours × 4) regimens produce sustained decreases in serum bicarbonate at 72 hours (from ~32 mEq/L to ~25 mEq/L) 3
  • The response does not differ between diuretic-treated and non-diuretic-treated patients 3

Adverse Effects and Precautions

  • No significant adverse effects were noted in clinical studies of acetazolamide for metabolic alkalosis 2
  • Monitor serum potassium, as amiloride may reduce potassium loss when used in combination with other diuretics 5
  • Acetazolamide is a weak diuretic but may help treat metabolic alkalosis associated with aggressive loop diuretic therapy 5

Common Pitfalls

  • Do not use acetazolamide before correcting fluid and electrolyte abnormalities, particularly hypokalemia (potassium should be ≥ 4 mEq/L) 3
  • Avoid routine use in pediatric cardiac patients post-congenital heart disease repair, as they demonstrate poor response compared to noncardiac patients 4
  • Do not assume multiple doses are necessary—a single 500 mg dose provides equivalent efficacy to divided dosing over 24 hours 3
  • High-dose loop diuretics (such as furosemide >160 mg/day) are associated with severe electrolyte disturbance and metabolic alkalosis and should be used cautiously 5

References

Research

Acetazolamide in the treatment of metabolic alkalosis in critically ill patients.

Heart & lung : the journal of critical care, 1991

Research

Acetazolamide therapy for metabolic alkalosis in critically ill pediatric patients.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treating severe metabolic alkalosis.

Clinical pharmacy, 1982

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.